Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
批准号:
9239284
负责人:
Subhra Chakraborty
金额:
$38.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-16 至 2020-05-31
关键词:
3 year old5 year oldAddressAgeAge-YearsAntibodiesAntigensApplications GrantsAreaBacteriaBenchmarkingBirthBlood Group AntigensBlood typing procedureCessation of lifeChildCohort StudiesCommunitiesDataData CollectionDetectionDevelopmentDiarrheaDiseaseEpidemiologyEscherichia coli InfectionsEscherichia coli VaccinesEtiologyEvaluationFecesFrequenciesFundingFutureGenotypeGeographic LocationsGrowthHistocompatibility Antigens Class IIHumanImmuneImmune responseImmune systemImmunityImmunizationImmunoglobulin AIncidenceInfantInfectionKineticsKnowledgeLifeMethodsMolecularMorbidity - disease rateNatural ImmunityNewborn InfantNorovirusNutritional statusParentsPatientsPeruPeruvianPhase III Clinical TrialsPublic HealthRegimenReportingResearchRiskRoleSalivaSapovirusSerumSiteSpecimenSymptomsTechniquesTechnologyTestingTimeToxinUnited States National Institutes of HealthVaccine DesignVaccinesWorkacquired immunitybaseblood groupcase controlco-infectioncohortcostcross reactivityefficacy trialenterotoxigenic Escherichia colinovelpathogenprotective effectresponsetime intervalvaccine development
中文摘要
项目摘要
产肠毒素大肠杆菌(ETEC)是引起腹泻的最常见原因,困扰着数百万人
发展中国家的儿童。然而,ETEC对幼儿的真正负担以及
获得性免疫力仍然知之甚少。不同地理区域的准确估计将
强调疫苗对公共卫生的重要性,这些数据对于减少
负担,并促进疫苗的开发。
成功开发疫苗的一个重大挑战是我们对免疫系统缺乏了解。
与预防ETEC疾病最相关的反应。更好地理解相互作用
非免疫和免疫受试者对不同ETEC菌株的局部和血清反应之间是
因为这些数据将为评估ETEC提供重要的免疫学基准
未来的疫苗和免疫方案。
我们建议将ETEC的研究添加到已经由NIH资助的诺沃克病毒和
利马郊区社区的沙普病毒感染,我们在那里进行了更多的儿童队列研究
不只是20年。通过利用这项研究,我们可以获得有关ETEC的信息,而成本只有
这是一项独立的研究.为了促进这项拟议的工作,我们正在与JHU ETEC研究机构合作
团队,提供专业知识和最先进的技术来评估ETEC疾病和
自然获得性免疫力。
正如在家长研究中一样,我们将通过纵向社区队列跟踪婴儿,以充分了解
对一种疾病的天然免疫力,这种疾病会在婴儿早期多次感染。我们将解决
解决ETEC流行病学和幼儿免疫反应的关键问题的知识差距
有效的疫苗设计和部署:我们将量化特定基因型的ETEC发病率和
发病率,我们将通过关联宿主血型抗原来评估保护性免疫的获得,
ETEC患者血清、粪便和唾液中的分泌物状态和ETEC抗原特异性抗体
疾病、感染和脱落。
具体目标1.通过进行纵向调查,描述秘鲁儿童ETEC的流行病学特征
从出生到3岁的队列研究,包括系统收集数据和标本。
具体目标2.评估在子集频繁暴露的情况下对ETEC的获得性保护性免疫
队列中的孩子。
英文摘要
Project Summary
Enterotoxigenic Escherichia coli (ETEC) are the most common cause of diarrhea, afflicting millions of
children in the developing world. However, the true burden of ETEC in young children and the role of
acquired immunity remains poorly understood. Accurate estimates in different geographic regions will
highlight the public health importance of a vaccine, and these data are critically important to reduce the
burden and to facilitate vaccine development.
A significant challenge to successful vaccine development is our poor understanding of the immune
responses that correlate best with protection against ETEC illness. A better understanding of the interplay
between local and serum responses to various ETEC strains in non-immune and immune subjects is
needed since these data will provide important immunological benchmarks for the evaluation of ETEC
vaccines and immunization regimens in the future.
We propose to add studies of ETEC to an already NIH-funded newborn cohort study of norovirus and
sapovirus infection in a peri-urban Lima community, where we have conducted child cohort studies for more
than 20 years. By leveraging this study, we can gain information about ETEC at a fraction of the cost were
it a stand-alone study. To facilitate this proposed work, we are collaborating with a JHU ETEC research
team, which provides access to expertise and state-of-the-art techniques to evaluate ETEC disease and
naturally-acquired immunity.
As in the parent study, we will follow the infants through a longitudinal community cohort to fully understand
the natural immunity to a disease that infects young infants multiple times early in life. We will address the
knowledge gap of ETEC epidemiology and immune response in young children by addressing issues key to
effective vaccine design and deployment: we will quantify the genotype-specific ETEC incidence and
morbidity, and we will evaluate acquisition of protective immunity by correlating host blood group antigen,
secretor status, and ETEC antigen specific antibodies in serum, fecal matter, and saliva with ETEC
disease, infection, and shedding.
Specific Aim 1. Characterize the epidemiology of ETEC in Peruvian children by conducting a longitudinal
cohort study from birth to age 3 years including systematic collection of data and specimens.
Specific Aim 2. Evaluate acquired protective immunity to ETEC in a setting of frequent exposure in a subset
of cohort children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of non-dysentery Shigella-associated diarrhea in children
-
批准号:10209109
-
项目类别:
-
资助金额:$40.68万
-
财政年份:2021
-
负责人:Subhra Chakraborty
-
依托单位:
The impact of non-dysentery Shigella-associated diarrhea in children
-
批准号:10368152
-
项目类别:
-
资助金额:$66.13万
-
财政年份:2021
-
负责人:Subhra Chakraborty
-
依托单位:
The impact of non-dysentery Shigella-associated diarrhea in children
-
批准号:10588251
-
项目类别:
-
资助金额:$66.59万
-
财政年份:2021
-
负责人:Subhra Chakraborty
-
依托单位:
The impact of non-dysentery Shigella-associated diarrhea in children
-
批准号:10247203
-
项目类别:
-
资助金额:$52.4万
-
财政年份:2020
-
负责人:Subhra Chakraborty
-
依托单位:
A novel diagnostic tool to aid vaccine evaluation and surveillance of enterotoxigenic E. coli and Shigella
-
批准号:9751198
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2018
-
负责人:Subhra Chakraborty
-
依托单位:
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
-
批准号:9091429
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2015
-
负责人:Subhra Chakraborty
-
依托单位:
海外基金